2019
DOI: 10.1186/s13024-019-0352-2
|View full text |Cite
|
Sign up to set email alerts
|

Synergistic effects of APOE and sex on the gut microbiome of young EFAD transgenic mice

Abstract: BackgroundAlzheimer’s disease (AD) is a fatal neurodegenerative disease. APOE4 is the greatest genetic risk factor for AD, increasing risk up to 15-fold compared to the common APOE3. Importantly, female (♀) APOE4 carriers have a greater risk for developing AD and an increased rate of cognitive decline compared to male (♂) APOE4 carriers. While recent evidence demonstrates that AD, APOE genotype, and sex affect the gut microbiome (GM), how APOE genotype and sex interact to affect the GM in AD remains unknown.Me… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
32
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 41 publications
(37 citation statements)
references
References 90 publications
5
32
0
Order By: Relevance
“…Inducing hypotension in a non-hypertensive AD patient is also likely to be considered a detrimental side effect. In addition, APOE4 is associated with several other peripheral changes such as alterations in metabolism, and the gut microbiome, any of which could have been modulated by ARB treatment ( Gregg et al, 1986 ; Bandaru et al, 2009 ; Maldonado Weng et al, 2019 ; Parikh et al, 2020 ). Taken together, further research could aid in evaluating the extent that the AT1 receptor in the periphery modulates inflammation in AD-relevant contexts and the development of novel ARBs that display higher brain penetration could limit clinical hypotensive effects of ARBs.…”
Section: Discussionmentioning
confidence: 99%
“…Inducing hypotension in a non-hypertensive AD patient is also likely to be considered a detrimental side effect. In addition, APOE4 is associated with several other peripheral changes such as alterations in metabolism, and the gut microbiome, any of which could have been modulated by ARB treatment ( Gregg et al, 1986 ; Bandaru et al, 2009 ; Maldonado Weng et al, 2019 ; Parikh et al, 2020 ). Taken together, further research could aid in evaluating the extent that the AT1 receptor in the periphery modulates inflammation in AD-relevant contexts and the development of novel ARBs that display higher brain penetration could limit clinical hypotensive effects of ARBs.…”
Section: Discussionmentioning
confidence: 99%
“…Apolipoprotein E is a transporter of cholesterol and it is present in the liver (80-90%), in the brain glia and macrophages. It was found to influence the structure and the function of the gut microbiome both in humans and mice (81,82). This suggests that the gut-brain axis is a potential target to reduce the impact of the APOE4 allele on cognitive decline and for the prevention of AD (81).…”
Section: Variability In Response To Nutraceuticals Intake: the Role Of The Gut-brain Axis And The Microbiome During Aging And Neurodegenementioning
confidence: 99%
“…Diet and housing conditions may markedly influence the composition of the gut microbiome [ 84 , 99 , 102 ] together with the age [ 103 ], gender [ 104 ] and the genotype of the mice [ 105 , 106 ]. However, gut microbiome in mice is mainly composed by bacteria belonging to the phylum Bacteroidetes , followed by phyla Firmicutes, Deferribacteres [ 99 , 101 ] and Proteobacteria [ 107 ], although the actual order depends on the studies [ 99 ].…”
Section: Diet Inflammation and Gut Microbiota In Ad Modelsmentioning
confidence: 99%